Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses

Journal of Virology

Volumn 89, Issue 7, 2015, Pages 3542-3556

  Bruel, Timothée ^a,b   Hamimi, Chiraz ^c,d,e   Dereuddre Bosquet, Nathalie ^a,b   Cosma, Antonio ^a,b   Shin, So Youn ^c,f   Corneau, Aurélien ^a,b   Versmisse, Pierre ^c   Karlsson, Ingrid ^a,g   Malleret, Benoit ^a,h   Targat, Brice ^a,b   Barré Sinoussi, Françoise ^c   Grand, Roger Le ^a,b   Pancino, Gianfranco ^c   Sáez Cirión, Asier ^c   Vaslin, Bruno ^a,b  

^a DIF   (France)

^b INSTITUT D'OPTIQUE GRADUATE SCHOOL   (France)

^c INSTITUT PASTEUR   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e INSERM   (France)

^f Kwandong University College of Medicine   (South Korea)

^g STATENS SERUM INSTITUT   (Denmark)

^h AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; DISEASE CARRIER; EX VIVO STUDY; IN VITRO STUDY; INFECTION CONTROL; MACACA FASCICULARIS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL DEPLETION; VIREMIA; VIRUS REPLICATION; ANIMAL; IMMUNOLOGY; LEUKAPHERESIS; SURVIVOR; VIROLOGY; VIRUS LOAD;

MACACA; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; LEUKOCYTE REDUCTION PROCEDURES; MACACA FASCICULARIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVORS; VIRAL LOAD;

EID: 84924807004     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03723-14     Document Type: Article

References (65)

1. Saez-Cirion A, Pancino G. 2013. HIV controllers: a genetically determined or inducible phenotype?. Immunol Rev 254:281-294. http://dx.doi.org/10.1111/imr.12076.
2. Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, Meyer L, Rouzioux C, Venet A, Delfraissy JF. 2005. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis 41:1053-1056. http://dx.doi.org/10.1086/433188.
3. Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, Chun TW, Churchill M, Di Mascio M, Katlama C, Lafeuillade A, Landay A, Lederman M, Lewin SR, Maldarelli F, Margolis D, Markowitz M, Martinez-Picado J, Mullins JI, Mellors J, Moreno S, O'Doherty U, Palmer S, Penicaud MC, Peterlin M, Poli G, Routy JP, Rouzioux C, Silvestri G, Stevenson M, Telenti A, Van Lint C, Verdin E, Woolfrey A, Zaia J, Barre-Sinoussi F. 2012. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 12:607-614. http://dx.doi.org/10.1038/nri3262.
4. Blankson JN, Bailey JR, Thayil S, Yang HC, Lassen K, Lai J, Gandhi SK, Siliciano JD, Williams TM, Siliciano RF. 2007. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J Virol 81:2508-2518. http://dx.doi.org/10.1128/JVI.02165-06.
5. Lamine A, Caumont-Sarcos A, Chaix ML, Saez-Cirion A, Rouzioux C, Delfraissy JF, Pancino G, Lambotte O. 2007. Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study). AIDS 21:1043-1045. http://dx.doi.org/10.1097/QAD.0b013e3280d5a7ac.
6. Miura T, Brockman MA, Brumme CJ, Brumme ZL, Carlson JM, Pereyra F, Trocha A, Addo MM, Block BL, Rothchild AC, Baker BM, Flynn T, Schneidewind A, Li B, Wang YE, Heckerman D, Allen TM, Walker BD. 2008. Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes. J Virol 82:8422-8430. http://dx.doi.org/10.1128/JVI.00535-08.
7. Carrington M, O'Brien SJ. 2003. The influence of HLA genotype on AIDS. Annu Rev Med 54:535-551. http://dx.doi.org/10.1146/annurev.med.54.101601.152346.
8. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivan J, Connors M. 2000. HLA Bz.ast;5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 97:2709-2714. http://dx.doi.org/10.1073/pnas.050567397.
9. Saez-Cirion A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F, Barre-Sinoussi F, Delfraissy JF, Sinet M, Pancino G, Venet A. 2007. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad SciUSA104:6776-6781. http://dx.doi.org/10.1073/pnas.0611244104.
10. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, Roederer M, Koup RA. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781-4789. http://dx.doi.org/10.1182/blood-2005-12-4818.
11. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, Van Baarle D, Kostense S, Miedema F, McLaughlin M, Ehler L, Metcalf J, Liu S, Connors M. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3:1061-1068. http://dx.doi.org/10.1038/ni845.
12. Saez-Cirion A, Sinet M, Shin SY, Urrutia A, Versmisse P, Lacabaratz C, Boufassa F, Avettand-Fenoel V, Rouzioux C, Delfraissy JF, Barre-Sinoussi F, Lambotte O, Venet A, Pancino G. 2009. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol 182:7828-7837. http://dx.doi.org/10.4049/jimmunol.0803928.
13. Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, Shin LY, Kovacs CM, Rodriguez B, Sieg SF, Teixeira-Johnson L, Gudonis D, Goepfert PA, Lederman MM, Frank I, Makedonas G, Kaul R, Walker BD, Betts MR. 2010. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 6:e1000917. http://dx.doi.org/10.1371/journal.ppat.1000917.
14. Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, Weeks KA, Rood JE, Berkley AM, Sacha JB, Cogliano-Shutta NA, Lloyd M, Roby G, Kwan R, McLaughlin M, Stallings S, Rehm C, O'Shea MA, Mican J, Packard BZ, Komoriya A, Palmer S, Wiegand AP, Maldarelli F, Coffin JM, Mellors JW, Hallahan CW, Follman DA, Connors M. 2008. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29:1009-1021. http://dx.doi.org/10.1016/j.immuni.2008.10.010.
15. Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, Martin JN, McCune JM, Deeks SG. 2008. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol 82:5398-5407. http://dx.doi.org/10.1128/JVI.02176-07.
16. Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, Rathod A, Baker B, Trocha A, Rosenberg R, Mackey E, Ueda P, Lu Z, Cohen D, Wrin T, Petropoulos CJ, Rosenberg ES, Walker BD. 2008. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 197:563-571. http://dx.doi.org/10.1086/526786.
17. Lecuroux C, Saez-Cirion A, Girault I, Versmisse P, Boufassa F, Avettand-Fenoel V, Rouzioux C, Meyer L, Pancino G, Lambotte O, Sinet M, Venet A. 2014. Both HLA-Bz.ast;57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers. J Virol 88:176-187. http://dx.doi.org/10.1128/JVI.02098-13.
18. Ndhlovu ZM, Proudfoot J, Cesa K, Alvino DM, McMullen A, Vine S, Stampouloglou E, Piechocka-Trocha A, Walker BD, Pereyra F. 2012. Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses. J Virol 86:6959-6969. http://dx.doi.org/10.1128/JVI.00531-12.
19. Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC, Zhang H, Margolick JB, Blankson JN, Siliciano RF. 2012. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36:491-501. http://dx.doi.org/10.1016/j.immuni.2012.01.014.
20. Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, Soma T, Bean AT, Beal DR, Wilson NA, Rehrauer WM, Lifson JD, Carrington M, Watkins DI. 2007. Mamu-Bz.ast;08-positive macaques control simian immunodeficiency virus replication. J Virol 81:8827-8832. http://dx.doi.org/10.1128/JVI.00895-07.
21. Pandrea I, Gaufin T, Gautam R, Kristoff J, Mandell D, Montefiori D, Keele BF, Ribeiro RM, Veazey RS, Apetrei C. 2011. Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion. PLoS Pathog 7:e1002170. http://dx.doi.org/10.1371/journal.ppat.1002170.
22. Schultheiss T, Schulte R, Sauermann U, Ibing W, Stahl-Hennig C. 2011. Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues. Retrovirology 8:24. http://dx.doi.org/10.1186/1742-4690-8-24.
23. Aarnink A, Dereuddre-Bosquet N, Vaslin B, Le Grand R, Winterton P, Apoil PA, Blancher A. 2011. Influence of the MHC genotype on the progression of experimental SIV infection in the Mauritian cynomolgus macaque. Immunogenetics 63:267-274. http://dx.doi.org/10.1007/s00251-010-0504-6.
24. Mee ET, Berry N, Ham C, Sauermann U, Maggiorella MT, Martinon F, Verschoor EJ, Heeney JL, Le Grand R, Titti F, Almond N, Rose NJ. 2009. Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaques. Immunogenetics 61:327-339. http://dx.doi.org/10.1007/s00251-009-0369-8.
25. Takahashi N, Nomura T, Takahara Y, Yamamoto H, Shiino T, Takeda A, Inoue M, Iida A, Hara H, Shu T, Hasegawa M, Sakawaki H, Miura T, Igarashi T, Koyanagi Y, Naruse TK, Kimura A, Matano T. 2013. A novel protective MHC-I haplotype not associated with dominant Gagspecific CD8+ T-cell responses in SIVmac239 infection of Burmese rhesus macaques. PLoS One 8:e54300. http://dx.doi.org/10.1371/journal.pone.0054300.
26. Yant LJ, Friedrich TC, Johnson RC, May GE, Maness NJ, Enz AM, Lifson JD, O'Connor DH, Carrington M, Watkins DI. 2006. The highfrequency major histocompatibility complex class I allele Mamu-Bz.ast;17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 80:5074-5077. http://dx.doi.org/10.1128/JVI.80.10.5074-5077.2006.
27. Friedrich TC, Valentine LE, Yant LJ, Rakasz EG, Piaskowski SM, Furlott JR, Weisgrau KL, Burwitz B, May GE, Leon EJ, Soma T, Napoe G, Capuano SV, III, Wilson NA, Watkins DI. 2007. Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication. J Virol 81:3465-3476. http://dx.doi.org/10.1128/JVI.02392-06.
28. Mudd PA, Ericsen AJ, Burwitz BJ, Wilson NA, O'Connor DH, Hughes AL, Watkins DI. 2012. Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers. J Immunol 188:3364-3370. http://dx.doi.org/10.4049/jimmunol.1102470.
29. Shacklett BL, Critchfield JW, Lemongello D. 2009. Isolating mucosal lymphocytes from biopsy tissue for cellular immunology assays. Methods Mol Biol 485:347-356. http://dx.doi.org/10.1007/978-1-59745-170-3_23.
30. Guenounou S, Bosquet N, Dembek CJ, Le Grand R, Cosma A. 2013. OMIP-016: Characterization of antigen-responsive macaque and human T-cells. Cytometry A 83:182-184. http://dx.doi.org/10.1002/cyto.a.22233.
31. Saez-Cirion A, Shin SY, Versmisse P, Barre-Sinoussi F, Pancino G. 2010. Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses. Nat Protoc 5:1033-1041. http://dx.doi.org/10.1038/nprot.2010.73.
32. O'Doherty U, Swiggard WJ, Malim MH. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74:10074-10080. http://dx.doi.org/10.1128/JVI.74.21.10074-10080.2000.
33. Karlsson I, Malleret B, Brochard P, Delache B, Calvo J, Le Grand R, Vaslin B. 2007. Dynamics of T-cell responses and memory T cells during primary simian immunodeficiency virus infection in cynomolgus macaques. J Virol 81:13456-13468. http://dx.doi.org/10.1128/JVI.01619-07.
34. Mannioui A, Bourry O, Sellier P, Delache B, Brochard P, Andrieu T, Vaslin B, Karlsson I, Roques P, Le Grand R. 2009. Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques. Retrovirology 6:106. http://dx.doi.org/10.1186/1742-4690-6-106.
35. Bernard-Stoecklin S, Gommet C, Corneau AB, Guenounou S, Torres C, Dejucq-Rainsford N, Cosma A, Dereuddre-Bosquet N, Le Grand R. 2013. Semen CD4+ T cells and macrophages are productively infected at all stages of SIV infection in macaques. PLoS Pathog 9:e1003810. http://dx.doi.org/10.1371/journal.ppat.1003810.
36. Muthukumar A, Wozniakowski A, Gauduin MC, Paiardini M, McClure HM, Johnson RP, Silvestri G, Sodora DL. 2004. Elevated interleukin-7 levels not sufficient to maintain T-cell homeostasis during simian immunodeficiency virus-induced disease progression. Blood 103:973-979. http://dx.doi.org/10.1182/blood-2003-03-0874.
37. Mueller YM, Do DH, Boyer JD, Kader M, Mattapallil JJ, Lewis MG, Weiner DB, Katsikis PD. 2009. CD8+ cell depletion of SHIV89.6Pinfected macaques induces CD4+ T cell proliferation that contributes to increased viral loads. J Immunol 183:5006-5012. http://dx.doi.org/10.4049/jimmunol.0900141.
38. Okoye A, Park H, Rohankhedkar M, Coyne-Johnson L, Lum R, Walker JM, Planer SL, Legasse AW, Sylwester AW, Piatak M, Jr, Lifson JD, Sodora DL, Villinger F, Axthelm MK, Schmitz JE, Picker LJ. 2009. Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. J Exp Med 206:1575-1588. http://dx.doi.org/10.1084/jem.20090356.
39. ten Haaft P, Almond N, Biberfeld G, Cafaro A, Cranage M, Ensoli B, Hunsmann G, Polyanskaya N, Stahl-Hennig C, Thortensson R, Titti F, Heeney J. 2001. Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection. J Med Primatol 30:207-214. http://dx.doi.org/10.1034/j.1600-0684.2001.d01-54.x.
40. Mudd PA, Ericsen AJ, Price AA, Wilson NA, Reimann KA, Watkins DI. 2011. Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers. J Virol 85:7454-7459. http://dx.doi.org/10.1128/JVI.00738-11.
41. Muhl T, Krawczak M, Ten Haaft P, Hunsmann G, Sauermann U. 2002. MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J Immunol 169:3438-3446. http://dx.doi.org/10.4049/jimmunol.169.6.3438.
42. O'Connor DH, Mothe BR, Weinfurter JT, Fuenger S, Rehrauer WM, Jing P, Rudersdorf RR, Liebl ME, Krebs K, Vasquez J, Dodds E, Loffredo J, Martin S, McDermott AB, Allen TM, Wang C, Doxiadis GG, Montefiori DC, Hughes A, Burton DR, Allison DB, Wolinsky SM, Bontrop R, Picker LJ, Watkins DI. 2003. Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. J Virol 77:9029-9040. http://dx.doi.org/10.1128/JVI.77.16.9029-9040.2003.
43. Greenier JL, Miller CJ, Lu D, Dailey PJ, Lu FX, Kunstman KJ, Wolinsky SM, Marthas ML. 2001. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J Virol 75:3753-3765. http://dx.doi.org/10.1128/JVI.75.8.3753-3765.2001.
44. Liu J, Keele BF, Li H, Keating S, Norris PJ, Carville A, Mansfield KG, Tomaras GD, Haynes BF, Kolodkin-Gal D, Letvin NL, Hahn BH, Shaw GM, Barouch DH. 2010. Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J Virol 84:10406-10412. http://dx.doi.org/10.1128/JVI.01155-10.
45. Durudas A, Chen HL, Gasper MA, Sundaravaradan V, Milush JM, Silvestri G, Johnson W, Giavedoni LD, Sodora DL. 2011. Differential innate immune responses to low or high dose oral SIV challenge in Rhesus macaques. Curr HIV Res 9:276-288. http://dx.doi.org/10.2174/157016211797635928.
46. Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Jr, Martin JN, Deeks SG, Shacklett BL. 2009. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 113:3978-3989. http://dx.doi.org/10.1182/blood-2008-10-182709.
47. Gulzar N, Copeland KF. 2004. CD8+ T-cells: function and response to HIV infection. Curr HIV Res 2:23-37. http://dx.doi.org/10.2174/1570162043485077.
48. Bosinger SE, Jochems SP, Folkner KA, Hayes TL, Klatt NR, Silvestri G. 2013. Transcriptional profiling of experimental CD8(+) lymphocyte depletion in rhesus macaques infected with simian immunodeficiency virus SIVmac239. J Virol 87:433-443. http://dx.doi.org/10.1128/JVI.01746-12.
49. Klatt NR, Shudo E, Ortiz AM, Engram JC, Paiardini M, Lawson B, Miller MD, Else J, Pandrea I, Estes JD, Apetrei C, Schmitz JE, Ribeiro RM, Perelson AS, Silvestri G. 2010. CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog 6:e1000747. http://dx.doi.org/10.1371/journal.ppat.1000747.
50. Dioszeghy V, Benlhassan-Chahour K, Delache B, Dereuddre-Bosquet N, Aubenque C, Gras G, Le Grand R, Vaslin B. 2006. Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression. J Virol 80:236-245. http://dx.doi.org/10.1128/JVI.80.1.236-245.2006.
51. Swain SL, McKinstry KK, Strutt TM. 2012. Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol 12:136-148. http://dx.doi.org/10.1038/nri3152.
52. Sacha JB, Giraldo-Vela JP, Buechler MB, Martins MA, Maness NJ, Chung C, Wallace LT, Leon EJ, Friedrich TC, Wilson NA, Hiraoka A, Watkins DI. 2009. Gag-and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection. Proc Natl Acad Sci USA 106:9791-9796. http://dx.doi.org/10.1073/pnas.0813106106.
53. Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, Ranasinghe S, Lindqvist M, Davis I, Lane K, Rychert J, Rosenberg ES, Piechocka-Trocha A, Brass AL, Brenchley JM, Walker BD, Streeck H. 2012. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med 4:123ra25. http://dx.doi.org/10.1126/scitranslmed.3003165.
54. Zheng N, Fujiwara M, Ueno T, Oka S, Takiguchi M. 2009. Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages. J Virol 83:7668-7677. http://dx.doi.org/10.1128/JVI.00513-09.
55. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit JT, Mittler J, Weinberger L, Kostrikis LG, Zhang L, Perelson AS, Ho DD. 1999. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189:991-998. http://dx.doi.org/10.1084/jem.189.6.991.
56. Leone A, Picker LJ, Sodora DL. 2009. IL-2, IL-7 and IL-15 as immuno-modulators during SIV/HIV vaccination and treatment. Curr HIV Res 7:83-90. http://dx.doi.org/10.2174/157016209787048519.
57. Ducrey-Rundquist O, Guyader M, Trono D. 2002. Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes. J Virol 76:9103-9111. http://dx.doi.org/10.1128/JVI.76.18.9103-9111.2002.
58. Unutmaz D, KewalRamani VN, Marmon S, Littman DR. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 189:1735-1746. http://dx.doi.org/10.1084/jem.189.11.1735.
59. Al-Harthi L, Roebuck KA, Landay A. 1998. Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production. J Clin Immunol 18:124-131. http://dx.doi.org/10.1023/A:1023246800353.
60. Smithgall MD, Wong JG, Critchett KE, Haffar OK. 1996. IL-7 upregulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J Immunol 156:2324-2330.
61. McChesney MB, Collins JR, Lu D, Lu X, Torten J, Ashley RL, Cloyd MW, Miller CJ. 1998. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 72:10029-10035.
62. Zhu T, Hu SL, Feng F, Polacino P, Liu H, Hwangbo Y, Learn GH, Mullins JI, Corey L. 2004. Persistence of low levels of simian immunodeficiency virus in macaques that were transiently viremic by conventional testing. Virology 323:208-219. http://dx.doi.org/10.1016/j.virol.2004.03.004.
63. Delwart E, Bernardin F, Lee TH, Winkelman V, Liu C, Sheppard H, Liu A, Greenblatt R, Anastos K, DeHovitz J, Nowicki M, Cohen M, Golub ET, Barbour J, Buchbinder S, Busch MP. 2011. Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women. AIDS 25:619-623. http://dx.doi.org/10.1097/QAD.0b013e3283440269.
64. Sahu GK, McNearney T, Evans A, Turner A, Weaver S, Huang JC, Baron S, Paar D, Cloyd MW. 2005. Transient or occult HIV infections may occur more frequently than progressive infections: changing the paradigm about HIV persistence. Arch Virol Suppl 19:131-145. http://dx.doi.org/10.1007/3-211-29981-5_11.
65. Zhu T, Corey L, Hwangbo Y, Lee JM, Learn GH, Mullins JI, McElrath MJ. 2003. Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J Virol 77:6108-6116. http://dx.doi.org/10.1128/JVI.77.11.6108-6116.2003.